BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/8/2023 9:38:25 AM | Browse: 419 | Download: 974
 |
Received |
|
2023-03-14 22:55 |
|
Peer-Review Started |
|
2023-03-14 22:57 |
|
First Decision by Editorial Office Director |
|
2023-04-11 01:39 |
|
Return for Revision |
|
2023-04-11 01:39 |
|
Revised |
|
2023-05-04 07:44 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-05-24 02:47 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-05-24 07:49 |
|
Articles in Press |
|
2023-05-24 07:49 |
|
Edit the Manuscript by Language Editor |
|
2023-05-23 01:13 |
|
Typeset the Manuscript |
|
2023-06-01 08:04 |
|
Publish the Manuscript Online |
|
2023-09-08 09:38 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Dermatology |
| Manuscript Type |
Case Report |
| Article Title |
Mepolizumab induced palmoplantar psoriasis: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Fabio Artosi, Laura Diluvio, Martina Vultaggio, Elena Campione and Luca Bianchi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fabio Artosi, MD, Academic Fellow, Doctor, Doctor, Department of Systems Medicine, University of Rome “Tor Vergata”, 81 Viale Oxford, Rome 00133, Italy. fabio.artosi994@gmail.com |
| Key Words |
Psoriasis; Interleukin-5; Mepolizumab; Asthma; Immunology; Case report |
| Core Tip |
We report the case of a 59-year-old patient with severe asthma who developed palmar psoriasis after 6 mo from the initiation of treatment with a humanized monoclonal antibody directed against interleukin-5 (IL-5), mepolizumab. There are several case reports of psoriasis induced by dupilumab therapy in the literature, but this phenomenon has not yet been recognized with modulating IL-5R signalling. This article reports the pathogenetic hypotheses that may underlie this phenomenon. |
| Publish Date |
2023-09-08 09:38 |
| Citation |
Artosi F, Diluvio L, Vultaggio M, Campione E, Bianchi L. Mepolizumab induced palmoplantar psoriasis: A case report. World J Clin Cases 2023; 11(26): 6154-6158
|
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i26/6154.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i26.6154 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
